Zoltan Villanyi

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

Highlights • FKBP10 is selectively expressed in lung cancer cells • Expression of FKBP10 negatively correlates with survival of lung cancer patients • FKBP10 downregulation suppresses cancer growth and cancer stem-like features • FKBP10 regulates translation elongation in particular upon insertion of proline Summary Cancer therapy is limited, in part, by lack of specificity.